EZH2 and small cell lung carcinoma: In small-cell lung cancer (SCLC), overexpressed EZH2 represses CCL2 expression by depositing H3K27me3 at its enhancer, reducing macrophage infiltration into tumors and highlighting EZH2’s role in immune evasion.